Of course. Here is the summary and tags based on the provided text.
**** Analysts at HC Wainwright have issued a Q1 2027 earnings estimate for Vanda Pharmaceuticals (VNDA), forecasting a loss of $0.28 per share. This information was published in a recent research report.
**
Comments